Transforming Treatment Through
Advanced Plant-Based Therapeutics
We are uncovering high-impact, plant-derived compounds with the power to reshape conventional approaches to disease treatment. Building on these discoveries, we develop next-generation medical analogs engineered for patented, licensable prescription therapeutics. Powered by our AI-driven discovery engine, we accelerate the identification and validation of promising drug candidates at unprecedented speed—bringing breakthrough innovation to the forefront of modern medicine and unlocking new value across the pharmaceutical landscape.
Trusted Relief, Healthier Lives
Naturemary is committed to creating safe, effective natural therapeutics that support pain relief, balance, and overall mental wellness.
The link between your mind and your body is more than a feeling. It’s a promising pathway for future therapeutic innovation.
.webp)
Shaping Scientific Progress
Supported by experts in neuroscience, chemistry, and machine learning, Naturemary uses advanced research and AI-guided discovery to create targeted natural therapeutics and analogs that help improve pain, balance, and overall wellbeing.
.webp)
Sonia Mary Kalra, Founder & CEO
A biologist and neuroscience researcher specializing in neural plasticity and sciatic nerve injury. An award- winning formulator, she has developed over 50 innovative neurotherapeutic products, bridging science and practical wellness solutions.
.webp)
Dr. Steven Jones, PHD
10+ years of experience of working and assessing the flow dynamics, mechanical properties, and biocompatibility of various medical devices (including stents, urinary and cardiovascular catheters, and assessment of collagen content of natural and xenograft materials)
Our Mission in Action
Naturemary Bio Pharma is a pioneering biotech company harnessing the power of AI and plant-based science to revolutionize modern medicine. We specialize in identifying and reengineering plant-derived molecules to develop innovative analogues with breakthrough potential in treating a wide range of diseases. At the intersection of nature and technology, our mission is to unlock the next generation of therapeutics for a healthier world.
Bridge consumer wellness with BioPharma innovation
Scaling from natural pain-relief CPG products to patented biopharma therapeutics, creating a dual-phase growth model.
Develop AI-enabled BioTerpene analogues
Using integrated computational and experimental design to create patentable therapeutic analogs with improved bioactivity.
.webp)
Provide safe, effective natural therapeutic delivery systems
solving current OTC market gaps by offering natural, scalable therapeutic solutions that outperform opioids, NSAIDs, and traditional topicals.
De-risk regulatory pathways for faster commercialization
leveraging GMP/QA verification, TCS, government agencies, and pre-market regulatory mapping to speed market readiness.
Our Executive Team
Our mission is to improve lives. We’re unlocking the potential of safe, science-backed natural therapeutics to help people feel better and live better.
Sonia Mary Kalra BSC, DHSA – Founder, Formulator and CEO
Founder & CEO
Sonia Mary Kalra is a recognized expert in mental health, dedicated to advancing research and improving the standard of care for individuals facing complex conditions.
.webp)
Kapil Kalra, Founder & President
Founder & president
Kapil Kalra is an experienced entrepreneur with a proven record in sales strategy, global export, and brand development. His portfolio includes multiple successful ventures and a strategic exit in 2018.
WAYNE MILLER
CHIEF Commercialization Officer
A growth-focused revenue leader with deep experience in sales strategy, partnerships, and go-to-market execution for purpose-driven consumer brands. with over 25 years of experience, he takes a hands-on, build-and-scale approach to driving sustainable revenue growth while staying grounded in mission, values, and real-world impact.